Advanced Proteome Therapeutics Corporation V.APC.H

$6,000,000,000 Target!!

[Goldnboy1]

Abbvie's Rova-T has had over $6B invested in it.

Rova-T failed in final stage clinical trials due to Off Target Toxicity. 

The patents $APC is just being issued will allow them to get Rova-T back to the clinic.

Due to the advanced state of Rova-T. This would mean a fast track to Final stage trials. For this the $APC ADC would be licenced or a joint development agreement signed.

When Trillium signed their joint development agreement with Pfizer to go to clinic. Their stock went from $0.30 to $1.50 in a matter of a few months. Then the Ofizer raise was announced.

At anytime a major like AbbVie or Pfizer could do the same thing here. There will always be a period where the buy up the market before they fund it. I believe this final quarter of 2022 will be the last quarter to buy $apc as a penny stock. 

One of $APC's patents have been dubbed by the US patent office as superior to a patent owned by Pfizer. Pfizer acquired this patent in 2009. But they have failed to commercialize it. 

$APC's patent runs circles around theirs. If they already care enough about this market to spend tens of millions on an inferior patent a decade ago. Just imagine what they might pay for the answer they are looking for today!

The majors are coming!! Long and strong!!

[Goldnboy1]

Gotta feel like if $apc can revive a $6B investment loss for AbbVie. That would make us worth in the very least  $600M. Seems reasonable for saving lives.  Keep in mind this is just one target and APC has multiple targets in their sights!  Reallt wanna see the one year chart fill its gap this week and then lift off from there!  Lots of good news is immenent!